Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Daily acetaminophen use may be bad for hypertension patients | Late-breaking clinical trials at ACC.22
Thursday, February 10, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Too much Tylenol? Daily acetaminophen use may be bad for hypertension patients

Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.

READ MORE >
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Share on Twitter Share on Facebook Share on Linkedin

Too much Tylenol? Daily acetaminophen use may be bad for hypertension patients

Share on Twitter Share on Facebook Share on Linkedin
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.
READ MORE >

Links to the ACC.22 late-breaking clinical trials

Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 

READ MORE >
The American College of Cardiology (ACC) annual meeting ACC.22 is the premier source for the latest cardiac science. #ACC22 Here are links to all the late breaking studies, trials and late-breaker science at the annual meeting conference. #ACC2022 #ACC
Share on Twitter Share on Facebook Share on Linkedin

Links to the ACC.22 late-breaking clinical trials

Share on Twitter Share on Facebook Share on Linkedin
The American College of Cardiology (ACC) annual meeting ACC.22 is the premier source for the latest cardiac science. #ACC22 Here are links to all the late breaking studies, trials and late-breaker science at the annual meeting conference. #ACC2022 #ACC
Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 
READ MORE >

Continued anticoagulation after primary PCI boosts survival among STEMI patients

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 

READ MORE >
elderly patient mask covid
Share on Twitter Share on Facebook Share on Linkedin

Continued anticoagulation after primary PCI boosts survival among STEMI patients

Share on Twitter Share on Facebook Share on Linkedin
elderly patient mask covid
A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 
READ MORE >

TAVR-related ischemic stroke linked to worse outcomes, higher Medicare costs

TAVR-related stroke, the authors wrote, is a "critically important and potentially preventable source of patient morbidity."

READ MORE >
older female patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

TAVR-related ischemic stroke linked to worse outcomes, higher Medicare costs

Share on Twitter Share on Facebook Share on Linkedin
older female patient and doctor
TAVR-related stroke, the authors wrote, is a "critically important and potentially preventable source of patient morbidity."
READ MORE >

Featured Articles

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

READ MORE >
The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.
Share on Twitter Share on Facebook Share on Linkedin

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

Share on Twitter Share on Facebook Share on Linkedin
The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.
The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.
READ MORE >

Long-term risk of heart attack, coronary artery disease or stroke much higher among COVID-19 patients

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues.

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

Long-term risk of heart attack, coronary artery disease or stroke much higher among COVID-19 patients

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues.
READ MORE >

IVUS guidance during DES implantation boosts long-term outcomes

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years. 

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

IVUS guidance during DES implantation boosts long-term outcomes

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years. 
READ MORE >

Clinical decision support may improve cardiac care at low-income community health centers

Evidence shows this technology has the potential to improve care for vulnerable patients with cardiovascular disease.

READ MORE >
An example of the CV Wizard clinical decision support (CDS) software showing a screen designed to help patients better understand their risks and areas they need to work on. It is graphically based to enable patients who have a lower level of literacy better understand their cardiovascular risks, rather than using a long text report.
Share on Twitter Share on Facebook Share on Linkedin

Clinical decision support may improve cardiac care at low-income community health centers

Share on Twitter Share on Facebook Share on Linkedin
An example of the CV Wizard clinical decision support (CDS) software showing a screen designed to help patients better understand their risks and areas they need to work on. It is graphically based to enable patients who have a lower level of literacy better understand their cardiovascular risks, rather than using a long text report.
Evidence shows this technology has the potential to improve care for vulnerable patients with cardiovascular disease.
READ MORE >

In Other News

Proposed legislation would extend coverage of telehealth services through 2024

The Telehealth Extension and Evaluation Act would allow the Centers for Medicare & Medicaid Services to extend Medicare payments for a wide range of telehealth services.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Proposed legislation would extend coverage of telehealth services through 2024

Share on Twitter Share on Facebook Share on Linkedin
The Telehealth Extension and Evaluation Act would allow the Centers for Medicare & Medicaid Services to extend Medicare payments for a wide range of telehealth services.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme